P. Jeffrey Conn

Displaying 1 - 4 of 4

Vanderbilt inks collaboration with Neumora Therapeutics, Inc to continue development of investigational treatment for neuropsychiatric disorders

Vanderbilt inks collaboration with Neumora Therapeutics, Inc to continue development of investigational treatment for neuropsychiatric disorders

Related Categories: 
Neumora Health and Medicine Research Aaron Bender Allison Gregro Basic Sciences Carrie Jones clinical pharmacology Colleen Niswender Craig Lindsley Darren Engers dopamine Jerri Rook Julie Engers Kayla Temple neuropsychiatric disorders Olivier Boutaud P. Jeffrey Conn precision medicine schizophrenia Tom Bridges WCNDD Warren Center for Neuroscience Drug Discovery

Vanderbilt-discovered drug candidate for Parkinson’s disease enters clinical trials

Vanderbilt-discovered drug candidate for Parkinson’s disease enters clinical trials

Related Categories: 
Appello Basic Sciences clinical trial clinical trials Craig Lindsley Craig W. Lindsley WCNDD Deerfield Management Research Jeffrey Conn P. Jeffrey Conn Parkinsons Parkinson’s disease Warren Center for Neuroscience Drug Discovery Appello Pharmaceuticals

Jeff Conn named 2021 fellow of American Society for Pharmacology and Experimental Therapeutics

Jeff Conn named 2021 fellow of American Society for Pharmacology and Experimental Therapeutics

Related Categories: 
Research ASPET Basic Sciences Jeffrey Conn P. Jeffrey Conn Pharmacology WCNDD Warren Center for Neuroscience Drug Discovery

Study explores potential new class of antidepressants

Study explores potential new class of antidepressants

Related Categories: 
Research antidepressants Department of Pharmacology glutamate Jeffrey Conn Max Joffe neuron P. Jeffrey Conn VCNDD Vanderbilt Center for Neuroscience Drug Discovery